688185.SS
688185.SS
CNE100004BM0
CANSINO BIOLOGICS INC
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.059.393.000 824.884.000
28.4%
Cost of Revenue 260.131.000 244.432.000
6.4%
Gross Profit 799.262.000 580.452.000
37.7%
784.566.000 937.220.000
16.3%
Operating Income 14.696.000 -356.768.000
104.1%
Pretax Income 21.738.000 -381.204.000
105.7%
Net Income Common Stockholders 27.873.000 -378.884.000
107.4%
-- --
--
-- --
--
ende